Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.46
+0.73 (2.46%)
Mar 14, 2025, 10:41 AM EDT - Market open
Viking Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,419 | 4,484 | 1,862 | 721 | 360 | 411 | |
| Market Cap Growth | 140.89% | 140.89% | 158.23% | 100.31% | -12.38% | -29.13% | |
| Enterprise Value | 2,436 | 3,555 | 1,487 | 567 | 144 | 156 | |
| Last Close Price | 29.73 | 40.24 | 18.61 | 9.40 | 4.60 | 5.63 | |
| PB Ratio | 3.77 | 5.09 | 5.34 | 4.96 | 1.78 | 1.68 | |
| P/TBV Ratio | 5.09 | 5.09 | 5.34 | 4.96 | 1.78 | 1.68 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | |
| Quick Ratio | 32.93 | 32.93 | 18.92 | 7.08 | 23.02 | 20.48 | |
| Current Ratio | 33.09 | 33.09 | 19.19 | 7.61 | 23.98 | 21.12 | |
| Return on Equity (ROE) | -17.90% | -17.90% | -34.79% | -39.67% | -24.65% | -15.15% | |
| Return on Assets (ROA) | -14.78% | -14.78% | -23.47% | -23.19% | -14.90% | -9.86% | |
| Return on Capital (ROIC) | -15.32% | -15.32% | -25.38% | -25.21% | -15.58% | -10.21% | |
| Earnings Yield | -3.30% | -2.45% | -4.61% | -9.55% | -15.28% | -9.62% | |
| FCF Yield | -2.63% | -1.96% | -3.94% | -6.71% | -13.22% | -5.30% | |
| Buyback Yield / Dilution | -15.57% | -15.57% | -22.79% | 0.47% | -6.34% | -0.89% | |
| Total Shareholder Return | -15.57% | -15.57% | -22.79% | 0.47% | -6.34% | -0.89% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.